New liquid biopsy could catch bladder cancer recurrence early
NCT ID NCT07441499
First seen Mar 08, 2026 · Last updated May 13, 2026 · Updated 8 times
Summary
This study is testing whether a simple blood or urine test (called a liquid biopsy) can help find, monitor, and predict the return of urothelial carcinoma, a type of bladder cancer. Researchers will compare these test results with standard tissue biopsies in 300 people who have or are suspected of having this cancer. The goal is to see if liquid biopsies can be a less invasive way to track the disease over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The second hospital of Tianjin Medical University
RECRUITINGTianjin, 300000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.